3rd Quarter - Report — SANOFI PASTEUR, INC. (FORMERLY AVENTIS… for SANOFI PASTEUR INC (FORMERLY AVENTIS PA… (2010) | LegiList

Firm

SANOFI PASTEUR, INC. (FORMERLY AVENTIS PASTEUR)

Client

SANOFI PASTEUR INC (FORMERLY AVENTIS PASTEUR)

Income

—

Expenses

$620,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Vaccine-related legislation, advance market commitments, and other issues

Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.

Lobbyist	Covered position, as disclosed
SEAN CALLINICOS	—
MARYANNE DOLBEARE DUNLAP	—
AMY L REDL	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE; Homeland Security, Dept of (DHS)

Taxation/Internal Revenue Code TAX

Legislation and other issues involving vaccine taxes and children's health, vaccine-related issues with respect to Medicaid and Medicare, and vaccine-related general tax issues.

Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.

Lobbyist	Covered position, as disclosed
SEAN CALLINICOS	—
MARYANNE DOLBEARE DUNLAP	—
AMY L REDL	—

Contacted: Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Patent reform issues

Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.

Lobbyist	Covered position, as disclosed
SEAN CALLINICOS	—
MARYANNE DOLBEARE DUNLAP	—
AMY L REDL	—

Contacted: Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Health Issues HCR

Vaccine and generic biological issues and related appropriation issues, including vaccines for children, pandemic concerns, influenza vaccine issues, stockpile, bioterrorism, bioterrorism countermeasures, vaccine injury compensation programs, vaccine safety, and FDA and CDC funding; implementation of health care reform legislation as it pertains to vaccines.

Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.

Lobbyist	Covered position, as disclosed
SEAN CALLINICOS	—
MARYANNE DOLBEARE DUNLAP	—
AMY L REDL	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); Executive Office of the President (EOP)

Medicare/Medicaid MMM

Vaccine-related Medicare and Medicaid issues, including those arising from implementation of health care reform legislation.

Foreign entity interest: Sanofi-Aventis Group has an interest in this legislation due to the potential impact on their U.S. business.

Lobbyist	Covered position, as disclosed
SEAN CALLINICOS	—
MARYANNE DOLBEARE DUNLAP	—
AMY L REDL	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Homeland Security, Dept of (DHS); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.